Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02002858 · ClinicalTrials.gov registry record · Phase 1
Smoking Cessation for Depression and Anxiety Treatment
A Phase 1 study, sponsored by University of Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT02002858: Completed Phase 1 study, sponsored by University of Houston.
NCT02002858 is a Phase 1 study that has completed, run by University of Houston. The registered enrollment target is 12 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02002858, a Phase 1 study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The primary aim of this research study is to enhance smoking cessation outcome among smokers with elevated anxiety and depression. We are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cessation, and anxiety and depression management treatment program (SDAT). Both treatments also utilize nicotine replacement therapy.
Primary Outcome
Participants will report the number of cigarettes they consumed everyday since their last visit. The number of cigarettes reported will be used to determine smoking status (e.g., 0 cigarettes reported is abstinent and any cigarettes reported is currently smoking).
Interventions
- DRUG Nicotine Patch
- BEHAVIORAL Depression and Anxiety Smoking Cessation Treatment
- BEHAVIORAL Educational-Support Psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-05 |
| Phase | Phase 1 |
What the finished NCT02002858 record still lists
NCT02002858 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 3 interventions - of which Nicotine Patch is the first listed.
NCT02002858 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02002858 about?
NCT02002858 is a clinical study titled "Smoking Cessation for Depression and Anxiety Treatment". The primary aim of this research study is to enhance smoking cessation outcome among smokers with elevated anxiety and depression. We are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cess...
What is the current status of trial NCT02002858?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2014-10. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02002858?
The interventions under investigation include: Nicotine Patch (DRUG), Depression and Anxiety Smoking Cessation Treatment (BEHAVIORAL), Educational-Support Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02002858?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02002858's enrollment target sits among peer trials
12 1852nd of 2000 higher than 90 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia